A soluble enzyme obtained from rat forebrain catalyzes the NADPH-dependent formation of nitric oxide (NO) and citrulline from L-arginine. The NO formed stimulates the soluble guanylate cyclase and this stimulation is abolished by low concentrations of hemoglobin. The synthesis of NO and citrulline is dependent on the presence of physiological concentrations of free Ca2+ and is inhibited by NG-monomethyl-L-arginine, but not by its enantiomer NGmonomethylDarginin e or by Lcanavanine. L-Homoarginine, L-argyl-L-apartate, or L-arginine methyl ester can replace L-ginine as substrates for the enzyme. These results indicate that NO is formed from Larginine in the brain through an enzymic reaction similar to that in vascular endothelial cells, neutrophils, and macrophages, adding support to our hypothesis that the formation of NO from L-arginine is a widespread transduction mechanism for the stimulation of the soluble guanylate cyclase. Activated macrophages also synthesize NOj and NO3 from the terminal guanido nitrogen atom(s) of L-arginine (5). This reaction, which occurs via the formation of NO (6), is involved in the cytotoxic activities of these cells (7). We have demonstrated recently that rat peritoneal neutrophils form NO from L-arginine (8).
of the macrophage has been suggested to be Mg2+ (6) .
Some years ago, L-arginine was identified as an endogenous activator of the soluble guanylate cyclase in brain tissue (10) . Since this activation resembled that of the nitrovasodilators (11) and NO is known to stimulate soluble guanylate cyclase in the brain (12) , we have investigated the existence in the central nervous system of an enzymic system capable of converting L-arginine into NO and citrulline.
While this work was in progress Garthwaite et al. (13) reported that N-methyl-D-aspartate, an excitatory amino acid known to elevate cyclic GMP levels in the brain, induces the release of an EDRF-like material from rat cerebellar cells.
MATERIALS AND GBq) and cyclic GMP radioimmunoassay kits were obtained from Amersham. NO (British Oxygen) was prepared as a 3% (vol/vol) solution as described (1) . L-MeArg and D-MeArg were synthesized as described (14) . Chelating resin (sodium form, 50-100 mesh, catalogue no. C7901) was obtained from Sigma. Other chemicals were obtained from Sigma or Aldrich. Preparation of Crude Synaptosomal Cytosol. Male rats (200-300 g, four for each preparation) were killed by cervical dislocation and the forebrains were rapidly removed and cooled in ice-cold washing buffer (0.32 M sucrose/10 mM Hepes/0.1 mM EDTA, pH 7.4); subsequent procedures were carried out at 0-40C. The tissue was placed in fresh washing buffer, finely minced, washed once with 50 ml of washing buffer and twice with homogenization buffer (0.32 M sucrose/10 mM Hepes, 1 mM DL-dithiothreitol, pH 7.4) to remove contaminating erythrocytes, and homogenized with 20 strokes of a Dounce homogenizer. The homogenate was diluted to 50 ml with homogenization buffer and centrifuged (1400 x g, 10 min); the supernatant obtained was centrifuged (18 ,000 x g, 10 min) to obtain a crude synaptosomal pellet. After aspiration of the supernatant, 8 ml of 1 mM DLdithiothreitol (dissolved in distilled water) was added to the pellet to cause hypotonic swelling of the synaptosomes, which were then lysed by homogenization as above. The soluble fraction was obtained as the supernatant from centrifugation at 150,000 x g for 30 min. This soluble fraction was passed through a 2-ml column of chelating resin to remove endogenous divalent cations and arginine (11) , and the synaptosomal cytosol was made up to 10 ml with 1 mM DL-dithiothreitol and stored on ice until used.
Determination of Cyclic GMP, NO, and Citrulline Forma- (12 ,000 x g, 1 min), the cyclic GMP was determined by radioimmunoassay in aliquots of the supernatants diluted 1:100 in 25 mM Tris/4 mM EDTA, pH 7.2 at 0°C. NO was measured as its breakdown product, NO-, following incubation as described above but terminated by the addition of EGTA to 1 mM and cooling on ice. NO-formed was determined by chemiluminescence, as described (1); in brief, 50-pI aliquots of incubates were injected into a reaction vessel containing 75 ml of 1% NaI in glacial acetic acid, the NO formed was removed under reduced pressure in a stream of nitrogen and mixed with ozone, and the resulting chemiluminescence was measured. The NO released was quantified by reference to NO standards.
Abbreviations: EDRF, endothelium-derived relaxing factor; MeArg, NG-monomethylarginine; SNAP, S-nitroso-N-acetylpenicillamine.
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Citrulline formation was determined in incubates that also included L-[3H]arginine (10 ,uCi/ml, 0.2 /uM); incubation was terminated with HC104 as above. The stimulation of guanylate cyclase at this concentration of L-arginine was below the limit of detection of this method. This low concentration of arginine was necessary in these experiments to maximize the specific activity of the L-[3H]arginine and therefore the sensitivity of the [3H]citrulline determination. Aliquots (100 tl) of supernatants were fractionated by ion-exchange highpressure liquid chromatography and the radioactivity in fractions corresponding to L-arginine, L-ornithine, and Lcitrulline was determined by liquid scintillation counting as described (9) .
Incubations at defined free Ca2l concentrations were carried out in the presence of 1 mM EGTA and up to 1.0 mM added CaCl2; the resulting free Ca2' concentrations were calculated as described by Fabiato and Fabiato (15) Results are expressed as mean ± SEM of n separate experiments. Statistical significance was determined by Student's t test, and P < 0.05 taken as significant.
RESULTS
Synthesis of NO and Citrulline. Addition of L-arginine (100 ,uM) and NADPH (1 mM) to incubations containing synaptosomal cytosol induced the synthesis of NO (40 ± 5.8 pmol/min per ml; n = 4), determined as its breakdown product NO-. The L-arginine-dependent NOj production was abolished by hemoglobin (1 ,uM, n = 3). The synthesis of NO was accompanied by stimulation of guanylate cyclase with half-maximal stimulation observed at 6 ± 2 ,M Larginine and saturation at =50 ,uM (n = 3). This stimulation was similar in magnitude to that induced by NO, sodium nitroprusside, or S-nitroso-N-acetylpenicillamine (SNAP) and was also abolished by hemoglobin ( Table 1) .
The guanylate cyclase stimulation by L-arginine (100 ,M) was maximal in the presence of exogenous NADPH (1 mM). In its absence the stimulation was only 40 ± 11.4% (n = 7) of that in its presence. This variation presumably reflects variability in the endogenous NADPH content of the synaptosomal cytosol preparations.
Incubation of synaptosomal cytosol with 0.2 ,uM L-
[3H]arginine and 1 mM NADPH also resulted in the synthesis of [3H]citrulline (44.9 ± 11.0 fmol/min per ml, n = 4). The rate of synthesis of citrulline from L-arginine was NADPHdependent; the rate in the absence of added NADPH was only 26 ± 7.0%o (n = 4) of that in its presence.
[3H]Omithine synthesis was not observed (n = 3). The time courses of NO formation, measured by guanylate cyclase stimulation and citrulline formation, were similar, reaching a maximum after 10-20 min (n = 3). Guanylate cyclase stimulation in the presence of L-arginine was linearly related to the square root of the rate of citrulline formation (Fig. 1 ).
Ca2' Dependence of NO and Citrulline Synthesis. When the free Ca2+ concentration in the incubations was controlled by Ca2+/EGTA buffers, the activity of the guanylate cyclase measured in the presence of either SNAP (10 ,uM) or NO (33 ,uM) was found to be inhibited by free Ca2+ concentrations above 80 nM, with a half-maximal effect at 120 nM and complete inhibition at 1.5 ,uM. Because of this, the stimulation of the guanylate cyclase by L-arginine at different free Ca2' concentrations was expressed as a percentage of the stimulation induced by 10 ,uM SNAP.
The synthesis of both NO and citrulline from L-arginine was found to be entirely Ca2l-dependent (Fig. 2) . Halfmaximal rates were observed at =160 nM and =170 nM, respectively, and no synthesis of either NO or citrulline was detectable below =80 nM free Ca2'.
Substrate and Inhibitor Specificity of the Enzyme. NO synthesis, measured by guanylate cyclase stimulation, was also observed when L-arginyl-L-aspartate, L-arginine methyl ester, or L-homoarginine was substituted for L-arginine ( Table 2 ). The concentrations of these three compounds causing half-maximal stimulation were 6 ± 0. Table 2 ).
DISCUSSION
The brain contains a soluble enzyme that forms NO from L-arginine in the presence of NADPH. This synthesis of NO can be determined either by measuring its breakdown product NO-or by measuring its ability to stimulate soluble guanylate cyclase (16) . Both NO-production and guanylate cyclase stimulation were abolished by hemoglobin, which binds NO, and by L-MeArg, which inhibits the NO-forming enzyme in endothelial cells (9) and macrophages (6) .
In addition to L-arginine, some L-arginine analogs also stimulated the guanylate cyclase with similar maximal effects, confirming a previous report (11) . This finding, together with the observation that their action was inhibited by L-MeArg, indicates that all these compounds are substrates for the NO-forming enzyme.
The concentrations of L-arginine, L-arginyl-L-aspartate, and L-arginine methyl ester required to produce half-maximal stimulation of guanylate cyclase were similar and were substantially less than that for L-homoarginine. Furthermore, L-MeArg was similarly effective as an inhibitor of approximately equally effective concentrations of these substrates. The half-maximally effective concentrations are not apparent Km or K, values for the NO-forming enzyme, since we were studying the result of the activity of two enzymes, namely, the NO-forming enzyme and the soluble guanylate cyclase. With the sensitivity of the present method it is not possible to measure NO formation directly at low substrate concentrations, and further work will be necessary to clarify the kinetics of NO formation from L-arginine by the NO-forming enzyme.
Citrulline is also formed from L-arginine by the synaptosomal cytosol. The correlation between NO and citrulline formation in terms of their time course, NADPH and Ca2' dependence, and inhibitor sensitivity suggests that they are coproducts of the same reaction. The observed relationship between NO and citrulline formation strongly supports this suggestion. NO decay is second-order at constant 02 concentration (17) . Therefore, for NO and citrulline to be products of the same reaction, there should be a square-root relationship between the rate of citrulline formation and the NO concentration, provided that the NO concentration is at steady state. Our results are consistent with this.
The NO-synthesizing enzyme from the brain is strikingly dependent on the free Ca2+ concentration in the physiological range. The enzyme is essentially inactive at the resting free Ca2+ concentration in synaptosomes (=80 nM; ref. 18 ), whereas it is fully active at concentrations >400 nM. This may constitute the physiological mechanism for stimulating the synthesis of NO, which is also Ca2+-dependent in cerebellar cells (13 The mechanism by which L-arginine is oxidized to citrulline and NO is not known. Studies in the macrophage led to the suggestion that the reaction could consist of arginine deimination followed by oxidation of NH3 to NO (5) . However, we did not observe any synthesis of NO when the synaptosomal preparation was incubated with 200 kLM NH4Cl. Furthermore, Na-benzoyl-L-arginine ethyl ester, a substrate for peptidyl-arginine deiminase (20) , was not a substrate, and formamidine, an inhibitor of bacterial arginine deiminase (21) , had no effect in the present study. On the basis of its NADPH dependence, we have suggested that the reaction in vascular endothelial cells is an oxygenation (9) . A more detailed mechanistic proposal has also come from recent work on the macrophage enzyme suggesting the existence of a monooxygenation reaction followed by the formation of NO and citrulline by hydrolysis (6) .
The enzymes in brain, macrophages, and endothelial cells that form NO from L-arginine share a number of characteristics: they are soluble, NADPH-dependent, and inhibited in an enantiomerically specific manner by L-MeArg (6, 9) . It is highly likely that the enzyme in the neutrophil, where we have recently described the formation of NO from L-arginine (8), shares these same characteristics. There are, however, some differences that are worth mentioning. The endothelial cell cannot utilize L-arginine methyl ester (2), unlike the brain enzyme or the macrophage (22) , and L-canavanine inhibits NO formation in the macrophage (23) and the neutrophil (8) but not in the brain or in endothelial cells (2) . Furthermore, the enzyme in the macrophage requires Mg2e for maximal activation (6) . Whether some of these differences are due to differences in the enzyme or in the uptake mechanisms requires clarification. It is, however, likely that these tissues contain distinct isoenzymes for the generation of NO from L-arglnine.
Our results provide an explanation for the observations of Deguchi and Yoshioka (10, 11) , who described an argininedependent stimulation of the soluble guanylate cyclase in the central nervous system that exhibited the characteristics of the stimulation by a nitrovasodilator. It is clear that they were dealing with the L-arginine/NO pathway. Furthermore, our results also explain those of Garthwaite et al. (13) , who described the release of an EDRF-like material from rat cerebellar cells stimulated with N-methyl-D-aspartate.
Our finding that the "EDRF" from the brain, like that from the vasculature, is NO further demonstrates the chemical nature of EDRF. Moreover, the occurrence of the Larginine/NO pathway in the brain, vascular endothelium, and phagocytic cells indicates that this is a widespread transduction mechanism whose major function is the stimulation of the soluble guanylate cyclase.
The soluble guanylate cyclase in the brain is widely distributed and is stimulated by a number of mediators (24) . It is therefore probable that in the central nervous system, as in other systems (25) , the L-arginine/NO pathway plays a crucial regulatory role, the modulation of which leads to a variety of as yet undefined biological consequences.
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